Category: Top Stories

The Best Places to Work 2020

The Best Places to Work 2020

March 25, 2020 |

In Florida, The Digest announced the 100 Best Places to Work in the Advanced Bioeconomy, as voted by the Digest’s readers. All organizations engaged in the advanced bioeconomy were eligible — producers, R&D institutions, labs, suppliers, growers, distributors, investors and partner, excepting academic or teaching institutions. In all, 297 different organizations received votes from readers in the […]

Read More

Fewer Wizards, Bigger Castles: As Zymergen acquires EnEvolv, the tension builds between Open Innovation and closed circles of high-end design and optimization

Fewer Wizards, Bigger Castles: As Zymergen acquires EnEvolv, the tension builds between Open Innovation and closed circles of high-end design and optimization

March 24, 2020 |

From San Francisco and Boston — peeking out from their shelters in place — news arrived Zymergen has acquired EnEvolv at the customary price of “terms were not disclosed”. There are a couple of streams to note here, within this storyline. The technical storyline. As the always quotable Kiwi Collin South puts it: “This partnership […]

Read More

The Hand Sanitizer Market: a salvation for beleaguered ethanol producers, or not?

The Hand Sanitizer Market: a salvation for beleaguered ethanol producers, or not?

March 23, 2020 |

If you’ve not heard, NuGenTec is looking for Distillers to help supply Ethanol for Hand Sanitizers in California! We have two automated bottling lines waiting for ethanol to produce 8oz and 16oz gel type hand sanitizers, they write. You can learn more here. And as we reported this morning, Aemetis is one of those companies […]

Read More

Pandemic won’t stop Impossible Foods – $500M new funding for Impossible’s R&D, retain expansion, next-gen products

Pandemic won’t stop Impossible Foods – $500M new funding for Impossible’s R&D, retain expansion, next-gen products

March 22, 2020 |

“I’m Possible” is even in Impossible Foods name and right now when so many things seem impossible, they are proof that even in a global pandemic, good things can still happen. Having just secured $500 million dollars in fresh funding, despite the global turmoil triggered by the coronavirus, they are showing anything is possible indeed. […]

Read More

Coronavirus Responses & Impacts Bioeconomy Survey Results – March 2020

Coronavirus Responses & Impacts Bioeconomy Survey Results – March 2020

March 19, 2020 |

During the week of March 16-20, 2020, The Digest surveyed its readers on how they were impacted by the Coronavirus health & economic crisis, and how they were responding. The bioeconomy’s pioneers are an optimistic bunch, and generally are far more optimistic than pessimistic about the next 12 months. That’s changed. Now, 70 percent are pessimists about 2020-21, relative […]

Read More

The Competitive Edge: Vertimass LLC

The Competitive Edge: Vertimass LLC

March 19, 2020 |

Q: What was the reason for founding your organization – what was the open niche you saw that could be addressed with a new product or service? What was the problem, or gap, or opportunity? Vertimass seeks to commercialize novel catalytic technology for low cost conversion of ethanol into hydrocarbon fuels to overcome obstacles that […]

Read More

Coronavirus Impact Bioeconomy Update: As oil prices plunge, Goldman predicts 2nd half stock recovery, up to 3 million deaths in US

Coronavirus Impact Bioeconomy Update: As oil prices plunge, Goldman predicts 2nd half stock recovery, up to 3 million deaths in US

March 18, 2020 |

In New York, crude oil prices plummeted to $22.78 (West Texas Intermediate) and $28.12 (Brent Crude), the lowest prices seen since 2002 for WTI, as world commodity, debt equity markets reeled from the expected economic impact of coronavirus safety measures. Natural gas prices closed at $1.68, while the Dow Jones Industrial Average sank 6.30 percent […]

Read More

Where are we? March 2020 Digest Data Dashboard, The Bioeconomy, By the Numbers

Where are we? March 2020 Digest Data Dashboard, The Bioeconomy, By the Numbers

March 18, 2020 |

Read More

First patient dosed with Moderna’s coronavirus vaccine candidate

First patient dosed with Moderna’s coronavirus vaccine candidate

March 17, 2020 |

Earlier this week, we focused in on technologies around messenger RNA, or mRNA, as key players in the search for a coronavirus vaccine. More news on that front. In Massachusetts, Moderna disclosed that the first participant has been dosed in the Phase 1 study of the Company’s mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2). […]

Read More

Cristal Union shifts from fuels to pharma-grade ethanol at Arcis plant in coronavirus response

Cristal Union shifts from fuels to pharma-grade ethanol at Arcis plant in coronavirus response

March 17, 2020 |

This news in from Cristal Union in France: “In the current context of an unprecedented health crisis, with an increasingly rapid spread of the Covid-19 virus, the Cristal Union Group has decided to stop the production of bioethanol at the Arcis distillery in Aube to redirect its production towards ethyl alcohol, labeled BIOCIDAL and PharmEthyl […]

Read More